Clinical outcomes of adult patients with primary intracranial germinomas treated with low-dose craniospinal radiotherapy and local boost.
The authors document the long term follow up of adult patients with histologically proven primary intracranial germinoma treated with radiotherapy alone using a craniospinal with local boost technique. A retrospective review was conducted on adults diagnosed with intracranial germinoma who received radiotherapy at the Princess Margaret Hospital, Toronto from 1990 to 2007. The study group consisted of 10 males with a median age of 24.1 years. All patients received radiotherapy alone using craniospinal radiotherapy and local boost. There were 10 patients (all male) with a median follow up of 10.9 years (range 2.2-18.9 years). At date of last follow up all patients were still alive, none with relapsed disease. Seven of ten patients (70%) had panhypopituitarianism prior to commencing radiotherapy and hormonal function was not affected in those with an intact pituitary axis. There was no reported cognitive decline in the treated cohort. For adult intracranial germinomas, with long term follow up, low-dose craniospinal radiotherapy with in field boost is highly effective with minimal morbidity.
Foote
M
M
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.
Millar
B-A
BA
Sahgal
A
A
Ménard
C
C
Payne
D
D
Mason
W
W
Laperriere
N
N
D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000532:radiotherapy*; D003072:Cognition Disorders / Q000209:etiology; D018572:Disease-Free Survival; D004703:Endocrine System / Q000528:radiation effects; D018237:Germinoma / Q000532:radiotherapy*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D016634:Radiosurgery / Q000009:adverse effects; D011879:Radiotherapy Dosage; D012189:Retrospective Studies; D015898:Tomography Scanners, X-Ray Computed; D016896:Treatment Outcome; D055815:Young Adult
Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):419-26
9308946
Neurosurgery. 1999 Dec;45(6):1292-7; discussion 1297-8
10598695
Radiology. 1978 Sep;128(3):745-51
674649
Cancer. 1988 Jun 1;61(11):2148-52
3365647
Oncologist. 2000;5(4):312-20
10964999
Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1165-70
15001260
Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):251-7
17707279
J Neurooncol. 2008 Nov;90(2):205-11
18604473
Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):511-8
12738328
Int J Radiat Oncol Biol Phys. 1990 Apr;18(4):773-81
2323968
Radiother Oncol. 2009 Apr;91(1):75-9
19019472
J Neurosurg. 1981 Dec;55(6):889-95
7299463
Br J Cancer. 1994 Nov;70(5):984-9
7947108
Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):481-5
16530341
Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):915-23
9276355
Surg Neurol. 1994 Sep;42(3):200-10
7940105
J Clin Oncol. 1999 Aug;17(8):2585-92
10561326
Radiother Oncol. 1996 Jan;38(1):19-23
8850422
Lancet Oncol. 2005 Jul;6(7):509-19
15992700
Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):511-5
9112446
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):705-13
14967424
Cancer. 2005 Jul 1;104(1):126-34
15895370
Pediatr Blood Cancer. 2008 Aug;51(2):313-6
18421722
Cancer. 2006 Nov 1;107(9):2228-36
17019739
Int J Radiat Oncol Biol Phys. 1988 Aug;15(2):291-7
3403312
Int J Radiat Oncol Biol Phys. 1988 Aug;15(2):285-90
3403311